Search people, articles, bills, and more
This bill matters because it addresses a critical gap in the "valley of death" for biotechnology innovations – the difficult transition from laboratory breakthroughs to commercially viable products. If it becomes law, it would provide crucial infrastructure and support for scaling up new bio-based technologies, which could lead to a more robust domestic manufacturing sector, create high-tech jobs, and enhance national energy security by diversifying our energy sources and supply chains.
Without this bill, many promising biotechnologies might struggle to advance past the research phase due to the high costs and risks associated with demonstrating commercial scale-up, potentially hindering U.S. competitiveness in a rapidly growing global industry and slowing the development of sustainable products and energy solutions.
No reactions yet. Be the first to weigh in.
This bill matters because it addresses a critical gap in the "valley of death" for biotechnology innovations – the difficult transition from laboratory breakthroughs to commercially viable products. If it becomes law, it would provide crucial infrastructure and support for scaling up new bio-based technologies, which could lead to a more robust domestic manufacturing sector, create high-tech jobs, and enhance national energy security by diversifying our energy sources and supply chains.
Without this bill, many promising biotechnologies might struggle to advance past the research phase due to the high costs and risks associated with demonstrating commercial scale-up, potentially hindering U.S. competitiveness in a rapidly growing global industry and slowing the development of sustainable products and energy solutions.
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)